Voyager Therapeutics Inc (NASDAQ: VYGR) stock enjoyed a major increase of 19.7% on 1/3/24. The shares closed at $10.77. Moreover, exceptionally high trading volume at 731% of normal accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 27.0% during the last week.
Current PriceTarget Research Rating
VYGR is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Voyager Therapeutics has a poor Power Rating of 20 and a very low Appreciation Score of 3, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment